These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 7383460)

  • 1. Cell-mediated cytotoxicity in preinvasive and invasive squamous cell carcinoma of the cervix.
    Dini MM; Jafari K; Faiferman I
    Obstet Gynecol; 1980 Jun; 55(6):728-31. PubMed ID: 7383460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-affinity erythrocyte rosette formation and inhibition in premalignant disease of the uterine cervix.
    Bashford J; Gough IR
    Cancer Res; 1983 Aug; 43(8):3955-8. PubMed ID: 6861158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillomavirus infection of the cervix. II. Relationship to intraepithelial neoplasia based on the presence of specific viral structural proteins.
    Kurman RJ; Jenson AB; Lancaster WD
    Am J Surg Pathol; 1983 Jan; 7(1):39-52. PubMed ID: 6299124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosette formation and inhibition in cervical dysplasia and carcinoma in situ.
    Sawanobori S; Ashman RB; Nahmias AJ; Benigno BB; LaVia MF
    Cancer Res; 1977 Dec; 37(12):4332-5. PubMed ID: 922724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of cervical intraepithelial neoplasia with primary adenocarcinoma of the endocervix.
    Maier RC; Norris HJ
    Obstet Gynecol; 1980 Sep; 56(3):361-4. PubMed ID: 7422175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunoperoxidase demonstration of papillomavirus antigen in dysplasia of the uterine cervix].
    Toki T; Oikawa N; Tase T; Wada Y; Yajima A; Suzuki M; Higashiiwai H
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Mar; 37(3):411-5. PubMed ID: 2984298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression of high-affinity rosette formation in dysplasia and carcinoma in situ of the uterine cervix: mediation by serum factors.
    Bashford J; Gough IR
    Cancer Res; 1983 Aug; 43(8):3959-62. PubMed ID: 6861159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical follow-up and the cell-mediated cytotoxicity against HeLa cells in patients with invasive or preinvasive cervical cancer.
    Saksela E; Meyer B
    Med Biol; 1976 Jun; 54(3):217-22. PubMed ID: 940364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical intraepithelial glandular neoplasia diagnosis and significance in relation to squamous precancerous lesions.
    Bhambhani S; Kaushik N; Khan IU; Luthram UK
    Indian J Cancer; 1990 Dec; 27(4):211-6. PubMed ID: 2090576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoantigen loss in cervical neoplasia. Demonstration by immunofluorescence and immunoperoxidase techniques.
    Bonfiglio TA; Feinberg MR
    Arch Pathol Lab Med; 1976 Jun; 100(6):307-14. PubMed ID: 57765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squamous cell carcinoma related antigen in uterine cervical carcinoma.
    Cheah PL; Yap SF; Looi LM; Sivanesaratnam V
    Malays J Pathol; 1991 Jun; 13(1):37-41. PubMed ID: 1795560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma.
    Rivera ES; Hersh EM; Bowen JM; Barnett JW; Wharton T; Murphy SG
    Cancer; 1979 Jun; 43(6):2297-305. PubMed ID: 455220
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlative light and immunohistological study of the HCG-like antigen in the squamous cell carcinoma of the human uterine cervix.
    Yamasaki M; Ueda G; Inoue M; Tanaka Y; Tanizawa O; Kurachi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):151-4. PubMed ID: 7014735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical carcinoma antigens in the diagnosis of human squamous cell carcinoma of the cervix.
    Haines HG; McCoy JP; Hofheinz DE; Ng AB; Nordqvist SR; Leif RC
    J Natl Cancer Inst; 1981 Mar; 66(3):465-74. PubMed ID: 7009947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological aspects of gynecological malignancies.
    DiSaia PJ
    J Reprod Med; 1975 Jan; 14(1):17-20. PubMed ID: 1110478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergence between the occurrence of antibody and cellular immune reactivity to cervical carcinoma cell lines in preinvasive and macroinvasive stages of cervical carcinoma.
    van de Linde AW; Streefkerk M; Schuurman HJ; te Velde ER; Kater L
    Br J Cancer; 1983 Jan; 47(1):147-53. PubMed ID: 6821628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunofluorescent study of basement membranes in squamous cell carcinoma of the cervix, vagina, and vulva.
    Pertschuk LP; Boyce JG; Urcuyo R
    Obstet Gynecol; 1977 Apr; 49(4):417-20. PubMed ID: 323765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune evaluation of cervical cancer patients--alteration of peripheral lymphocyte subpopulations--(author's transl)].
    Ishiguro T
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):719-24. PubMed ID: 6972426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmosomes and gap junctions in precarcinomatous and carcinomatous conditions of squamous epithelia. An electron microscopic and morphometrical study.
    Kocher O; Amaudruz M; Schindler AM; Gabbiani G
    J Submicrosc Cytol; 1981 Apr; 13(2):267-81. PubMed ID: 7338968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.